T1	Participants 58 85	biliary and gastric surgery
T2	Participants 137 187	80 patients undergoing biliary or gastric surgery.
T3	Participants 192 281	patients were randomized to receive 1 g of aztreonam or 80 mg of gentamicin intravenously
